Cargando…
Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
Maintenance of atrial fibrillation is a complex mechanism, including extensive electrical and structural remodeling of the atria which involves progressive fibrogenesis. Galectin-3 is a biomarker of fibrosis, and, thus, may be involved in atrial remodeling in atrial fibrillation patients. We review...
Autores principales: | Clementy, Nicolas, Piver, Eric, Bisson, Arnaud, Andre, Clémentine, Bernard, Anne, Pierre, Bertrand, Fauchier, Laurent, Babuty, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979515/ https://www.ncbi.nlm.nih.gov/pubmed/29587379 http://dx.doi.org/10.3390/ijms19040976 |
Ejemplares similares
-
Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
por: Clementy, Nicolas, et al.
Publicado: (2018) -
Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
por: Clementy, Nicolas, et al.
Publicado: (2016) -
Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
por: Andre, Clémentine, et al.
Publicado: (2018) -
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017) -
Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy
por: Bisson, Arnaud, et al.
Publicado: (2018)